Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
В. Т. Ивашкин(Institute of Electronic Measurements KVARZ (Russia)), Минара Шамхаловна Шамхалова, Kh. B. Kodzoeva(Sechenov University), В. В. Бредер, N. V. Korochanskaya(Kuban State Medical University), И. В. Маев(Moscow State University of Medicine and Dentistry), В. Л. Дощицин(Pirogov Russian National Research Medical University), М. В. Шестакова, Nana Pogosova(National Medical Research Center of Cardiology), Alexander Yur'evich Mayorov, K. A. Komshilova(Endocrinology Research Center), М. V. Maevskaya(Sechenov University), Ekaterina Е. Mishina(Endocrinology Research Center), Е. А. Трошина, М. С. Жаркова(Sechenov University), Е. N. Dudinskaya(Pirogov Russian National Research Medical University), О. Н. Ткачева, Е. В. Ершова, И. Г. Никитин(Pirogov Russian National Research Medical University), N. I. Gheivandova(Stavropol Regional Clinical Oncology Center), А. И. Тарзиманова(Sechenov University), M. Yu. Nadinskaya(Sechenov University), Yu. V. Kotovskaya
Russian Journal of Gastroenterology Hepatology Coloproctology
September 30, 2022
Cited by 71
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
|The Lancet|2023|676
Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
|Journal of Clinical Oncology|2022|398
The Concept of Folic Acid in Health and Disease
|Molecules|2021|284